切换至 "中华医学电子期刊资源库"

中华产科急救电子杂志 ›› 2015, Vol. 04 ›› Issue (01) : 5 -9. doi: 10.3877/cma.j.issn.2095-3259.2015.01.002

所属专题: 文献

专家论坛

妊娠合并白血病
张晓红1,(), 王大鹏1   
  1. 1. 100044 北京大学人民医院妇产科
  • 收稿日期:2014-09-11 出版日期:2015-02-18
  • 通信作者: 张晓红

Leukemia in pregnancy

Xiaohong Zhang1(), Dapeng Wang1   

  • Received:2014-09-11 Published:2015-02-18
  • Corresponding author: Xiaohong Zhang
引用本文:

张晓红, 王大鹏. 妊娠合并白血病[J/OL]. 中华产科急救电子杂志, 2015, 04(01): 5-9.

Xiaohong Zhang, Dapeng Wang. Leukemia in pregnancy[J/OL]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2015, 04(01): 5-9.

妊娠合并白血病是一个极其严重的产科合并症,母胎均面临高度风险。孕期应警惕患者血常规化验的异常结果,以及早诊断。孕期诊断的白血病患者需由产科、血液科综合管理,争取更好的母胎结局。本文就妊娠合并白血病的诊断、对母胎的影响、孕期的处理以及治疗过程中的伦理等问题进行讨论。

Leukemia in pregnancy is a severe obstetric complication, threatening the life of the mother and the baby. Abnormal indexes of blood test during prenatal care should be noticed to diagnose leukemia as soon as possible. The pregnant patients with leukemia should be treated under the obstetrician and hematologist to expect better maternal and fetal outcomes. In this article, the authors discussed the diagnosis, impact on mothers and fetus, obstetric management and the ethic issue of leukemia in pregnancy.

[1]
Hurley TJ. McKinnell JV, Irani MS. Hematologic malignancies in pregnancy[J]. Obstet Gynecol Clin North Am, 2005, 32(4):595-614.
[2]
Lavi N, Horowitz NA, Brenner B. An update on the management of hematologic malignancies in pregnancy[J]. Womens Health (Lond Engl), 2014, 10(3):255-266.
[3]
Ali R, Ozkalemkas F, Ozcelik T, et al. Maternal and fetal outcomes in pregnancy complicated with acute leukemia: a single institutional experience with 10 pregancies at 16 years[J]. Leuk Res, 2003, 27(5):381-385
[4]
王大鹏,梁梅英,张晓红,等. 妊娠合并白血病23例临床分析[J]. 中华围产医学杂志,2014, 17(2):93-98.
[5]
Döhner H, Estey EH, Amadori S, et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet[J]. Blood, 2010, 115(3):453-474.
[6]
葛均波,徐永健. 内科学[M]. 8版. 北京:人民卫生出版社,2013:578.
[7]
Ali R, Ozkalemkas F, Ozkocaman V, et al. Successful pregnancy and delivery in a patient with chronic myelogenous leukemia(CML), and management of CML with leukapheresis during pregnancy:a case report and review of the literature[J]. Jpn J Clin Oneol, 2004, 34(4):215-217.
[8]
Saleh AJ, Alhejazi A, Ahmed SO, et al. Leukemia during pregnancy: long term follow up of 32 cases from a single institution[J]. Hematol Oncol Stem Cell Ther, 2014, 7(2):63-68.
[9]
Avivi I, Brenner B. Management of acute myeloid leukemia during pregnancy[J]. Future Oncol, 2014, 10(8):1407-1415.
[10]
Nomura RM, Igai AM, Faciroli NC, et al. Maternal and perinatal outcomes in pregnant women with leukemia[J]. Rev Bras Ginecol Obstet, 2011, 33(8):174-181.
[11]
Milojkovic D, Apperley JF. How I treat leukemia during pregnancy[J]. Blood, 2014, 123(7):974-984.
[12]
Chang A, Patel S. Treatment of acute myeloid leukemia during pregnancy[J]. Ann Pharmacother, 2015, 49(1):48-68.
[13]
Sanz MA, Jarque I, Martin G, et al. Acute promyelocytic leukemia. Therapy results and prognostic factors[J]. Cancer, 1988, 61(1):7-13.
[14]
Chelghoum Y, Vey N, Raffoux E, et al. Acute leukemia during pregnancy:a report on 37 patients and a review of the literature[J]. Cancer, 2005, 104(1):110-117.
[15]
Shapira T, Pereg D, Lishner M. How I treat acute and chronic leukemia in pregnancy[J]. Blood Rev, 2008, 22(5):247-259.
[16]
王大鹏,梁梅英,张晓红,等. 妊娠合并慢性粒细胞性白血病患者的临床处理特点及妊娠结局分析[J]. 中华妇产科杂志,2010, 45(10):735-739.
[17]
Yazdani Brojeni P, Matok I, Garcia Bournissen F, et al. A systematic review of the fetal safety of interferon alpha[J]. Reprod Toxicol, 2012, 33(3):265-268.
[18]
Webb MJ, Jafta D. Imatinib use in pregnancy[J]. Turk J Hematol, 2012, 29(4):405-408.
[19]
Yadav U, Solanki SL, Yadav R. Chronic myeloid leukemia with pregnancy: Successful management of pregnancy and delivery with hydroxyurea and imatinib continued till delivery[J]. J Cancer Res Ther, 2013, 9(3):484-486.
[20]
Mukhopadhyay A, Dasgupta S, Kanti Ray U, et al. Pregnancy outcome in chronic myeloid leukemia patients on imatinib therapy[J]. Ir J Med Sci, 2015, 184(1):183-188.
[21]
Azim HA Jr, Pavlidis N, Peccatori FA. Treatment of the pregnant mother with cancer: a systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part II: Hematological tumors[J]. Cancer Treat Rev, 2010, 36(2):110-121.
[1] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[2] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[3] 李代勤, 刘佩杰. 动态增强磁共振评估中晚期低位直肠癌同步放化疗后疗效及预后的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 100-103.
[4] 屈翔宇, 张懿刚, 李浩令, 邱天, 谈燚. USP24及其共表达肿瘤代谢基因在肝细胞癌中的诊断和预后预测作用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 659-662.
[5] 顾雯, 凌守鑫, 唐海利, 甘雪梅. 两种不同手术入路在甲状腺乳头状癌患者开放性根治性术中的应用比较[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 687-690.
[6] 付成旺, 杨大刚, 王榕, 李福堂. 营养与炎症指标在可切除胰腺癌中的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 704-708.
[7] 关小玲, 周文营, 陈洪平. PTAAR在乙肝相关慢加急性肝衰竭患者短期预后中的预测价值[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 841-845.
[8] 张润锦, 阳盼, 林燕斯, 刘尊龙, 刘建平, 金小岩. EB病毒相关胆管癌伴多发转移一例及国内文献复习[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 865-869.
[9] 陈晓鹏, 王佳妮, 练庆海, 杨九妹. 肝细胞癌VOPP1表达及其与预后的关系[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 876-882.
[10] 韩加刚, 王振军. 梗阻性左半结肠癌的治疗策略[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 450-458.
[11] 董佳, 王坤, 张莉. 预后营养指数结合免疫球蛋白、血糖及甲胎蛋白对HBV 相关慢加急性肝衰竭患者治疗后预后不良的预测价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 555-559.
[12] 刘郁, 段绍斌, 丁志翔, 史志涛. miR-34a-5p 在结肠癌患者的表达及其与临床特征及预后的相关性研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 485-490.
[13] 陈倩倩, 袁晨, 刘基, 尹婷婷. 多层螺旋CT 参数、癌胚抗原、错配修复基因及病理指标对结直肠癌预后的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 507-511.
[14] 曾明芬, 王艳. 急性胰腺炎合并脂肪肝患者CT 与彩色多普勒超声诊断参数与其病情和预后的关联性研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 531-535.
[15] 王景明, 王磊, 许小多, 邢文强, 张兆岩, 黄伟敏. 腰椎椎旁肌的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 846-852.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?